RecruitingNot applicableNCT06746909

Identification of Neuroinflammation and Neuroimaging Biomarkers Through Data Driven Artificial Intelligence Techniques for Unraveling the Heterogeneity of Aged Subjects at Risk of Dementia and to Better Inform Prevention Strategies

Studying Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS Fondazione Stella Maris
Intervention
Multidomain cognitive training and physical training(other)
Enrollment
115 target
Eligibility
65-89 years · All sexes
Timeline
20222026

Study locations (1)

Collaborators

Humanitas Research Hospital IRCCS, Rozzano-Milan · Azienda Ospedaliero, Universitaria Pisana · Istituto di Neuroscienze Consiglio Nazionale delle Ricerche

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06746909 on ClinicalTrials.gov

Other trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

Additional recruiting or active studies for the same condition.

See all trials for Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome

← Back to all trials